Companies to Watch 2023

Seven AI/ML innovators with the potential to accelerate drug discovery and development

Artificial intelligence and machine learning hold tremendous potential to identify new molecules and accelerate drug development to deliver innovative medicines to patients faster. Clarivate analysts identified seven promising early-stage companies working on AI and machine learning applications for drug discovery and development and identified critical best practices and trends in this emerging technology, including:

  • The astonishing growth in IP creation and scientific knowledge around AI/ML for the life sciences over the past decade
  • The emergence of an AI/ML for life sciences hub in Mainland China to rival those in the United States
  • Partnering strategies large pharmas are pursuing to incorporate potentially transformational AI/ML platforms into their R&D operations

Download the report to learn more about the trends shaping this fast-moving space and which AI/ML companies are ones to watch.

Got questions? To speak with one of our market specialists, please contact us here.